Complete relief from cancer! U.S. drug test yields groundbreaking results

According to a New York Times report, a trial claimed that 18 rectal cancer patients had been given the same medication for six months and that the treatment had completely eliminated each patient's cancer.

Cancer is still a big threat to the world today. Medical science is performing new miracles every day. In the meantime, a drug trial has been conducted, in which each patient has been released from cancer. Eighteen patients involved in the initial testing of a drug for the treatment of rectal cancer have been cured of the disease.

The New York Times reports that in a very small clinical trial, 18 patients took a drug called Dosterlimab for about six months, and in the end, the tumors in each of them disappeared.

Dusterlimumab is a laboratory-produced molecular drug that acts as an alternative antibody (alternative antibody) in the human body. All 18 rectal cancer patients were given the same drug and as a result of the treatment, all the patients' cancers were completely eradicated. Physical examinations such as endoscopy, positron emission tomography or PET scan or MRI scan also showed no signs of cancer.

It happened for the first time in history: Dr. Louis

Dr. Lewis A. of the Memorial Sloan Kettering Cancer Center in New York. This is "the first time in the history of cancer," Diaz J said. Dr. Diaz is one of the authors of the study. During the trial, it was revealed that patients took the drug every three weeks for six months. Significantly, all patients had the same stage of their cancer. It was in her anus, but did not spread to other parts of her body.

According to the New York Times, patients in clinical trials have so far undergone chemotherapy, radiation and invasive surgery ... in previous treatments to eradicate their cancer, which can lead to bowel, urinary and even sexual dysfunction. 18 patients went for testing hoping to tolerate this at a later stage. However, he did not need any further treatment.

Cancer patients are usually treated rigorously with surgery, chemotherapy and radiation. In the case of rectal cancer, some patients also need a colostomy bag. Patients sometimes have permanent problems such as bowel, urinary incontinence and even sexual dysfunction.

Complete eradication of cancer in all patients: Dr. Allen

The results of this test have spread panic in the medical world. Speaking to the media, Dr. Alan P. Venuk, who works as a colorectal cancer specialist at the University of California, Los Angeles, said that eradicating cancer from all patients was "incredible." He described the study as the first of its kind in the world, where all patients recovered. He added that it was particularly impressive because not all patients experienced significant complications during the trial drug. The special thing is that no side effects of this drug have been observed.

There were tears of joy in the eyes of the patients

Dr. Andrea Cerseck, an oncologist at the Memorial Sloan Kettering Cancer Center and co-author of the research paper, talks about the moment patients learned they were cancer-free. "They all had tears of joy in their eyes," he told the New York Times. Now, cancer researchers are reviewing the drug, telling the media that the treatment looks promising, but that a larger trial is needed to see if it will work for more patients and if the cancer is really gone.

Dusterlimumab is a monoclonal drug that acts as an antibody in the human body. Monoclonal antibodies work together with a special protein called PD-1 on the surface of cancer cells. It helps the immune system to detect and destroy cancer cells.

Tests like this are done

At the time of the test, patients were given this dose every three weeks for six months. None of the patients included in the trial underwent chemotherapy or surgery. During this time, the cancer did not spread from the rectum to other parts of the body, nor did any patient's health deteriorate.

So is the price of medicine

In the United States, a 500 mg dose of Dusterlimumab costs about লাখ 8 million ($ 11,000). Whereas, in the UK it is available at, 5,887 per dose.